QbD Group
    Case Study

    GMP Support for Closing CAPAs Across Quality Assurance, Qualification & Validation, and Software

    Learn how QbD Group helped a biotech CDMO close CAPAs across Quality Assurance, Qualification & Validation, and Software, strengthening GMP compliance and audit readiness.

    2026年2月3日2 分钟阅读
    Biotech CDMO

    QbD Group supported a biotech CDMO in strengthening its GMP compliance by successfully closing all planned CAPAs across Quality Assurance, Qualification & Validation,and Software. This hands-on, risk-based support ensured sustainable improvements in processes, documentation, and regulatory readiness, helping the client reduce risk and enhance overall operational quality.

    挑战

    The client needed to effectively close several open CAPAs stemming from internal audits and regulatory requirements, within a highly demanding GMP environment.

    The main challenge was implementing robust and sustainable solutions across Quality Assurance, Qualification & Validation, and Software, within tight deadlines, while minimizing regulatory risk and meeting the expectations of health authorities.

    方法

    QbD Group provided end-to-end GMP support, working closely with the client’s teams across QA, Qualification & Validation, and Software.

    The approach included:

    • Developing master documents and SOPs from scratch, and improving existing SOPs

    • Optimizing key processes and addressing audit-related deviations using risk-based tools

    • Ensuring continuous follow-up until final CAPA closure, guaranteeing long-term sustainability

    This practical, collaborative approach ensured full compliance and measurable improvements in the client’s GMP systems.

    结果

    The project achieved 100% closure of planned CAPAs, with all corrective and preventive actions meeting GMP requirements and regulatory expectations.

    As a result, the client significantly reduced regulatory risk, strengthened quality, validation, and software systems, and improved audit and inspection readiness.

    QbD Group’s support was instrumental in effectively closing our CAPAs and strengthening our GMP systems. Their hands-on, risk-based approach enabled us to implement sustainable solutions and significantly improve our regulatory readiness.

    GMP Quality Auditor at Biotech CDMO

    QbD Group

    Ready to take the next step?

    准备加速您的生命科学项目?与我们的专家交流。

    获取专家指导 →
    分享本文

    继续阅读

    相关内容

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.